Downstream Processing Featured Articles
-
Company Recognized For Outstanding Contributions To The Pharmaceutical Sciences
5/30/2012
Morphotek®, Inc., a subsidiary of Eisai Inc., announced today that The American Association of Pharmaceutical Scientists (AAPS) has awarded its 2012 Excellence in Ligand Binding Assays Award to the Bioanalytical Development group from Morphotek for their abstract, “Development and Validation of a Pharmacokinetic Assay on the Gyrolab Platform for Use in Phase II/III Clinical Studies.” The award was presented at the AAPS 2012 National Biotechnology Conference held May 21-23 in San Diego.
-
Lpath Receives First U.S. Patent For Anti-LPA Antibody, Lpathomab
4/25/2012
Lpath, Inc. (OTCBB: LPTN), the industry leader in lipidomics-based therapeutics, received official notification from the U.S. Patent and Trademark Office (USPTO) that it has been issued a key patent protecting Lpathomab™, a monoclonal antibody against lysophosphatidic acid (LPA).
-
Single-Use BioFlex Tubing Assemblies Featured In New Brochure
8/25/2011
Meissner has just released a new brochure featuring its BioFlex tubing assemblies. The single-use tubing assemblies are designed for secure fluid transfer in critical biopharmaceutical processing applications.
-
Galapagos Receives EUR2.5 Million IWT Grant For IBD Research
1/30/2013
Galapagos NV (Euronext: GLPG) announced today that it has been awarded a EUR2.5 million grant from the Flemish agency for Innovation by Science and Technology (IWT) for inflammatory bowel disease (IBD) research and development. The goal of this 2.5-year project is to identify new therapeutic compounds for future treatment of IBD patients.
-
Pathobiology Professor's Vaccine Platform Gives Immune Systems A Boost
11/28/2012
Dr. Bernhard Kaltenboeck, professor of pathobiology in Auburn University’s College of Veterinary Medicine, and research associates Erfan Chowdhury and Yihang Li have developed a vaccine platform to treat intracellular diseases for which antibodies are ineffective.
-
New 'Binary Technology' Boosts Plasmid DNA Purification Efficiency and Throughput
11/7/2001
The Aurumâ„¢ family of plasmid DNA purification systems is designed to significantly increase speed and consistency, from the highest-throughput 96-well applications through small-scale column studies.
-
MicroRNAs Can Convert Normal Cells Into Cancer Promoters
11/21/2012
Unraveling the mechanism that ovarian cancer cells use to change normal cells around them into cells that promote tumor growth has identified several new targets for treatment of this deadly disease.
-
MMRGlobal Targets Phase 3 Biotech Companies To Combine Assets With Life Sciences Group
11/19/2012
MMRGlobal, Inc. (
OTCBB : MMRF) today announced that through its wholly owned subsidiary, MMR Life Sciences Group, the Company plans on exploiting its pipeline of biotech assets by facilitating a partnership or other joint venture with a privately held biotech company that has completed its Phase 2 clinical trials and is in the process of beginning Phase 3. -
MorphoSys And Heptares Sign Alliance To Develop Antibody Therapeutics Targeting GPCRs
2/13/2013
MorphoSys AG (Prime Standard Segment, TecDAX) and UK-based Heptares Therapeutics, the leading GPCR drug discovery and development company, have signed an agreement to discover novel antibody therapeutics targeting G protein-coupled receptors (GPCRs), which are membrane proteins involved in a broad range of biological processes and diseases.
-
Stellar Biotechnologies Announces Filing A US Letters Patent Application
10/4/2012
Stellar Biotechnologies, Inc. ("Stellar" or the "Company") (TSX VENTURE: KLH) (PINKSHEETS: SBOTF) (FRANKFURT: RBT) is very pleased to announce the filing of a US Letters Patent Application directed to protecting certain proprietary KLH manufacturing controls, KLH formulations and kits used in immunotoxicology and immune status testing which were invented by Drs. Chow, Sundsmo and Sagermann.